Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
-
Field
-
As well as exciting opportunities this role presents, we also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find out more. Our commitment to Equality
-
promoting equality, diversity and inclusion is essential. What we offer As well as exciting opportunities this role presents, we also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards
-
, diversity and inclusion is essential. What we offer As well as the exciting opportunities this role presents, we also offer some great benefits, visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits
-
will uncover the interfacial solvation structure, validated through comparison between computed and experimental sum-frequency vibrational spectroscopies, as well as the mechanism of chemical
-
Electrodes (Nextrode). This project brings together lithium-ion electrode manufacturing expertise from Universities across the UK (Oxford, Birmingham, Warwick, Southampton and UCL). As Research Associate in
-
UIT and other technical teams to implement solutions. Collaborate with stakeholders to define site goals, user flows, and content needs. Conduct audits of existing sites and recommend structural
-
industry. We are connected with leading international institutions: UCL, UMC Utrecht, Charité Berlin, TU Dresden. We also collaborate with domestic clinical partners, enabling the direct application
-
that provides essential structural support to blood vessels. We and others have shown that mutations in COL4A1 or COL4A2 (encoding collagen IV proteins) cause familial and sporadic haemorrhagic, indicating
-
through professional development is expected, and independence, curiosity, and a positive attitude is required in a busy admissions environment. The PA IV is the first face of UCLS and should be a positive
-
immunoblotting and immunofluorescence microscopy. References: F. O. Kok, H. Wang, P. Riedlova, C. S. Goodyear, R. J. Carmody, Defining the structure of the NF-ĸB pathway in human immune cells using quantitative